OTCPK:BUENF - Post by User
Post by
blueblackon Jun 20, 2016 4:11pm
252 Views
Post# 24981279
FROM NR TODAY
FROM NR TODAY"While we are disappointed that the Phase 3 study did not meet the primary efficacy endpoint, the full data set will be assessed to determine the best path forward," said Roberto Bellini, President and Chief Executive Officer of BELLUS Health.
Read more at https://www.stockhouse.com/news/press-releases/2016/06/20/bellus-health-announces-top-line-phase-3-results-of-kiacta-for-the-treatment-of#EjWgXxRtpuF5BJWx.99
WHICH TO ME MEANS THEY HAVE A PLAN!!! IT WILL BOUNCE BACK !!!